Position in INSM
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$4,725,728
-$79,491,320 QoQ
Shares Held
28,900
-95.1% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 20261832 Asset Management L.P. holds $136,938,098 across 8 Biotechnology names. INSM ranks #6 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
84,200 | $61,487,050 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
356,400 | $26,466,264 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
143,800 | $24,305,076 | |
| 4 | KRYS |
Krystal Biotech, Inc.
|
42,600 | $11,004,432 | |
| 5 | INCY |
Incyte Corp
|
74,053 | $6,969,868 | |
| 6 | INSM |
INSMED Inc
This page
|
28,900 | $4,725,728 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,000 | $1,545,280 | |
| 8 | EPRX |
Eupraxia Pharmaceuticals Inc.
|
60,000 | $434,400 |
All Filings in INSM
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,725,728 | 28,900 | Shares | Sole | 2026-05-14 | |
| 2025-09-30 | $84,217,048 | 584,800 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $37,214,262 | 487,800 | Shares | Sole | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||